secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001104659-24-059674
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics enters $175M ATM equity offering with Leerink Partners
----------------------------------------------------------------------------

- New Sales Agreement with Leerink Partners for at-the-market offering of up to $175M common stock.
- Prior $125M ATM program with BofA Securities terminated on May 10, 2024.
- Leerink will receive up to 3% commission on gross proceeds from shares sold.
- Company has no obligation to sell shares and may suspend or terminate the program at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924059674/0001104659-24-059674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924059674/tm2413802d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-059674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer